I think you will find I used the AKP analogy right at the...

I think you will find I used the AKP analogy right at the beginning of this move in PO3 as to potential market cap for the company, the difference being that FRG addresses markets multiples of those of the AKP technology.

Assuming Hydroplasma is a winner, PO3 has potential solutions for some of the world's greatest environmental and medical problems, which places the company centre stage in the ESG narrative.

There will always be doubters, especially following the lack of performance until the new management was announced and the new business plan implemented, however once AS gave his blessing to the tech, I felt reassured that it's only a matter of execution and not "if" but rather "when".

Hopefully "when" is imminent as all us loyal holders deserve the pay day.